Study Title
LCH-IV: International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
Protocol ID
LCH-IV
Condition/s
Langerhans Cell Histiocytosis
Diagnosis Stage
New diagnosis
Location
NSW, QLD, VIC, WA, NZ, TAS
Sponsor
North American Consortium for Histiocytosis
Collaborators
Histiocyte Society
Links
Trial Status
Closed to Recruitment
Trial Close Date
30/11/2025
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital, Melbourne
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
The Royal Children's Hospital, Melbourne
Royal Hobart Hospital
Christchurch Hospital, NZ
Starship Hospital, NZ
John Hunter Children's Hospital
Monash Children's Hospital, Melbourne
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
The Royal Children's Hospital, Melbourne
Royal Hobart Hospital
Christchurch Hospital, NZ
Starship Hospital, NZ
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 18 years
International registry ID's
NCT02205762
| Study Title | LCH-IV: International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis |
|---|---|
| Protocol ID | LCH-IV |
| Disease (Sub Disease) | Langerhans Cell Histiocytosis |
| Diagnosis Stage | New diagnosis |
| Location | NSW / QLD / VIC / WA / NZ / TAS |
| Sponsor | North American Consortium for Histiocytosis |
| Collaborators | Histiocyte Society |
| Links | https://clinicaltrials.gov/ct2/show/NCT02205762 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 14/04/2014 |
| Trial Close Date | 30/11/2025 |
| Sites | The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital, Melbourne/ Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / The Royal Children's Hospital, Melbourne/ Royal Hobart Hospital/ Christchurch Hospital, NZ/ Starship Hospital, NZ |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 18 years |
| International registry ID's | NCT02205762 |